About Scleral Lens
Scleral lenses rest on the sclera and entirely vault the cornea letting it to hold a fluid reservoir. It was uniquely designed so that it can effectively fit a wide variety of corneal and scleral geometries. Numerous fitting sets are not necessary to fit oblate and prolate corneas. The scleral contact lens is designed to manage mild to severe levels of corneal irregularity and ocular surface disease. They are designed to land mildly on the sclera, without causing any compression or strain to the underlying tissue. Large-diameter gas permeable (GP) lenses offer similar advantages that conventional GP lenses have compared with soft contacts.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Scleral Lens is highly competitive, with several key players dominating the industry. The market players are focused on developing a variety of features and benefits to meet the needs and preferences of consumers. Thus, constantly introducing new innovation in processing to meet the changing needs and preferences of consumers. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Vendors will contribute the maximum growth to Global Scleral Lens market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Johnson & Johnson (United States), EssilorLuxottica (France), ZEISS (Germany), Rodenstock (Germany), ABB Optical (United States), Bausch Health (Canada), Visionary Optics (United States), Art Optical (United States), CooperVision (United States), AccuLens (United States), Tru-Form Optics (United States) and SynergEyes (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are Euclid Systems (United States), Bausch & Lomb (Canada) and Others.
Segmentation Overview
AMA Research has segmented the market of Global Scleral Lens market by Type (Corneo and Semi-Scleral Lenses, Mini-Scleral Lenses and Large-Scleral Lenses), Application (Hospital, Eye Clinic and Others) and Region.
On the basis of geography, the market of Scleral Lens has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Online will boost the Scleral Lens market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increasing Safety Measures and Usage in all the Age Group and Growing Trends in the Fashion Industry
Market Growth Drivers:
Growing Number of Ophthalmic Patients, Increasing Adoption of Scleral Lenses across the Globe and Comparatively Comfortable than Wearing Glasses
Restraints:
Careless Usage can Harm Eye Sights and Lack of Well Equipped Practitioners
Opportunities:
Technological Advancements in Scleral Lens Manufacturing and Increasing Awareness about the Scleral Lenses in Emerging Economies
Market Leaders and their expansionary development strategies
In April 2022, Euclid Vision, a global leader in advanced orthokeratology and proactive myopia management initiatives, announced its acquisition of Visionary Optics, a specialty scleral contact lens design and distribution pioneer. The acquisition signifies Euclid’s recognition of the value of joining forces with Visionary Optics, the only company in the US that concentrates almost exclusively on scleral contact lenses.
In February 2023, Visionary Optics launched Europa Tangent, a new scleral lens that provides customizable design and a three-zone step-system for optimal fitting.
Key Target Audience
Hospitals, Research and Development, Investor and Regulatory Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.